Avalo Therapeutics, Inc. Quarterly Return On Assets in % from Q2 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Avalo Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2016 to Q3 2024.
  • Avalo Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -9.06 %, a 91.6% increase year-over-year.
  • Avalo Therapeutics, Inc. annual Return On Assets for 2023 was -114 %, a 12.2% decline from 2022.
  • Avalo Therapeutics, Inc. annual Return On Assets for 2022 was -102 %, a 8.81% increase from 2021.
  • Avalo Therapeutics, Inc. annual Return On Assets for 2021 was -111 %, a 5.16% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -9.06 +98.8 +91.6% Jul 1, 2024 Sep 30, 2024
Q2 2024 -51.3 +24.7 +32.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -288 -203 -237% Jan 1, 2024 Mar 31, 2024
Q4 2023 -114 -12.4 -12.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 -108 -11 -11.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -76 +30.3 +28.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -85.5 +15 +14.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -102 +9.81 +8.81% Oct 1, 2022 Dec 31, 2022
Q3 2022 -96.8 +24.5 +20.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -106 +27.3 +20.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -100 +23.6 +19% Jan 1, 2022 Mar 31, 2022
Q4 2021 -111 +6.06 +5.16% Oct 1, 2021 Dec 31, 2021
Q3 2021 -121 -32.6 -36.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -134 -62.3 -87.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -124 -63.7 -106% Jan 1, 2021 Mar 31, 2021
Q4 2020 -117 -89.2 -316% Oct 1, 2020 Dec 31, 2020
Q3 2020 -88.7 -53.1 -150% Jul 1, 2020 Sep 30, 2020
Q2 2020 -71.2 -6.84 -10.6% Apr 1, 2020 Jun 30, 2020
Q1 2020 -60.4 +3.12 +4.92% Jan 1, 2020 Mar 31, 2020
Q4 2019 -28.2 +32.2 +53.3% Oct 1, 2019 Dec 31, 2019
Q3 2019 -35.5 +27.7 +43.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -64.4 -76 -657% Apr 1, 2019 Jun 30, 2019
Q1 2019 -63.5 -91.4 -327% Jan 1, 2019 Mar 31, 2019
Q4 2018 -60.4 -119 -203% Oct 1, 2018 Dec 31, 2018
Q3 2018 -63.2 -185 -152% Jul 1, 2018 Sep 30, 2018
Q2 2018 11.6 +197 Apr 1, 2018 Jun 30, 2018
Q1 2018 27.9 +194 Jan 1, 2018 Mar 31, 2018
Q4 2017 58.9 +204 Oct 1, 2017 Dec 31, 2017
Q3 2017 122 +243 Jul 1, 2017 Sep 30, 2017
Q2 2017 -185 -94.5 -104% Apr 1, 2017 Jun 30, 2017
Q1 2017 -166 Jan 1, 2017 Mar 31, 2017
Q4 2016 -145 Oct 1, 2016 Dec 31, 2016
Q3 2016 -121 Jul 1, 2016 Sep 30, 2016
Q2 2016 -90.9 Apr 1, 2016 Jun 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.